NDC 0032-1203-70
Creon 15000 [USP'U]/1
Pancrelipase · CAPSULE, DELAYED RELEASE
Creon is an oral medication containing pancrelipase that helps people digest food by replacing digestive enzymes the pancreas cannot produce. It is used to treat pancreatic insufficiency, a condition where the pancreas does not make enough enzymes to break down fats, proteins, and carbohydrates properly.
Key Facts
- Brand Name
- Creon
- Generic Name
- Pancrelipase
- NDC Code (Package)
0032-1203-70- NDC Code (Product)
0032-1203- Manufacturer
- AbbVie Inc.
- Strength
- 15000 [USP'U]/1
- Dosage Form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- BLA020725
- Marketing Start
- 04/30/2009
Recall History
No Recall HistoryView Full Drug Page
Creon — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.